nodes	percent_of_prediction	percent_of_DWPC	metapath
Pazopanib—CYP1A2—schizophrenia	0.229	0.43	CbGaD
Pazopanib—CYP2D6—schizophrenia	0.177	0.332	CbGaD
Pazopanib—ABCB1—schizophrenia	0.126	0.237	CbGaD
Pazopanib—Rilpivirine—CYP1A2—schizophrenia	0.0026	0.645	CrCbGaD
Pazopanib—Rilpivirine—ABCB1—schizophrenia	0.00143	0.355	CrCbGaD
Pazopanib—TAOK1—midbrain—schizophrenia	0.00125	0.00638	CbGeAlD
Pazopanib—KIT—blood plasma—schizophrenia	0.00124	0.00631	CbGeAlD
Pazopanib—PLK4—gonad—schizophrenia	0.00124	0.00628	CbGeAlD
Pazopanib—SLCO1B1—blood plasma—schizophrenia	0.00123	0.00627	CbGeAlD
Pazopanib—PI4KB—telencephalon—schizophrenia	0.00122	0.00619	CbGeAlD
Pazopanib—ITK—endocrine gland—schizophrenia	0.00121	0.00615	CbGeAlD
Pazopanib—SH2B3—blood—schizophrenia	0.0012	0.00608	CbGeAlD
Pazopanib—SH2B3—midbrain—schizophrenia	0.00118	0.006	CbGeAlD
Pazopanib—FGFR3—gonad—schizophrenia	0.00115	0.00584	CbGeAlD
Pazopanib—TAOK1—endocrine gland—schizophrenia	0.0011	0.0056	CbGeAlD
Pazopanib—PLK4—blood—schizophrenia	0.00108	0.00547	CbGeAlD
Pazopanib—PIP4K2C—telencephalon—schizophrenia	0.00107	0.00543	CbGeAlD
Pazopanib—FGFR1—telencephalon—schizophrenia	0.00106	0.00539	CbGeAlD
Pazopanib—MAP3K9—brain—schizophrenia	0.00105	0.00534	CbGeAlD
Pazopanib—FGF1—forebrain—schizophrenia	0.00104	0.00528	CbGeAlD
Pazopanib—STK36—gonad—schizophrenia	0.00103	0.00525	CbGeAlD
Pazopanib—TAOK1—nervous system—schizophrenia	0.00103	0.00524	CbGeAlD
Pazopanib—AURKC—endocrine gland—schizophrenia	0.00102	0.00519	CbGeAlD
Pazopanib—STK16—blood—schizophrenia	0.00102	0.00517	CbGeAlD
Pazopanib—PI4KB—gonad—schizophrenia	0.00102	0.00517	CbGeAlD
Pazopanib—MAP3K2—telencephalon—schizophrenia	0.00101	0.00515	CbGeAlD
Pazopanib—LYN—blood—schizophrenia	0.00101	0.00512	CbGeAlD
Pazopanib—RIOK2—blood—schizophrenia	0.001	0.00509	CbGeAlD
Pazopanib—LIMK2—gonad—schizophrenia	0.000997	0.00507	CbGeAlD
Pazopanib—TAOK1—central nervous system—schizophrenia	0.000993	0.00505	CbGeAlD
Pazopanib—FGFR3—midbrain—schizophrenia	0.000988	0.00503	CbGeAlD
Pazopanib—RIOK2—midbrain—schizophrenia	0.000988	0.00503	CbGeAlD
Pazopanib—FGFR2—forebrain—schizophrenia	0.00098	0.00498	CbGeAlD
Pazopanib—SH2B3—nervous system—schizophrenia	0.000971	0.00494	CbGeAlD
Pazopanib—TAOK1—cerebellum—schizophrenia	0.00097	0.00493	CbGeAlD
Pazopanib—AURKC—nervous system—schizophrenia	0.000956	0.00486	CbGeAlD
Pazopanib—FGF1—telencephalon—schizophrenia	0.000954	0.00485	CbGeAlD
Pazopanib—SH2B3—central nervous system—schizophrenia	0.000935	0.00475	CbGeAlD
Pazopanib—PLK4—endocrine gland—schizophrenia	0.000934	0.00475	CbGeAlD
Pazopanib—AURKC—central nervous system—schizophrenia	0.00092	0.00468	CbGeAlD
Pazopanib—SH2B3—cerebellum—schizophrenia	0.000913	0.00464	CbGeAlD
Pazopanib—CYP3A4—urine—schizophrenia	0.00091	0.00463	CbGeAlD
Pazopanib—FGFR2—telencephalon—schizophrenia	0.000901	0.00458	CbGeAlD
Pazopanib—STK36—blood—schizophrenia	0.000899	0.00457	CbGeAlD
Pazopanib—EPHB6—forebrain—schizophrenia	0.000898	0.00456	CbGeAlD
Pazopanib—CYP2D6—urine—schizophrenia	0.000895	0.00455	CbGeAlD
Pazopanib—PIP4K2C—gonad—schizophrenia	0.000891	0.00453	CbGeAlD
Pazopanib—PI4KB—blood—schizophrenia	0.000885	0.0045	CbGeAlD
Pazopanib—STK16—endocrine gland—schizophrenia	0.000882	0.00448	CbGeAlD
Pazopanib—PI4KB—midbrain—schizophrenia	0.000874	0.00445	CbGeAlD
Pazopanib—LYN—endocrine gland—schizophrenia	0.000873	0.00444	CbGeAlD
Pazopanib—LIMK2—blood—schizophrenia	0.000869	0.00442	CbGeAlD
Pazopanib—FGFR3—endocrine gland—schizophrenia	0.000868	0.00441	CbGeAlD
Pazopanib—BMPR1B—endocrine gland—schizophrenia	0.000859	0.00437	CbGeAlD
Pazopanib—TAOK3—forebrain—schizophrenia	0.000856	0.00435	CbGeAlD
Pazopanib—PDGFRA—forebrain—schizophrenia	0.000851	0.00433	CbGeAlD
Pazopanib—MAP3K2—gonad—schizophrenia	0.000845	0.0043	CbGeAlD
Pazopanib—FLT1—telencephalon—schizophrenia	0.000835	0.00425	CbGeAlD
Pazopanib—EPHB6—telencephalon—schizophrenia	0.000825	0.0042	CbGeAlD
Pazopanib—STK16—nervous system—schizophrenia	0.000825	0.0042	CbGeAlD
Pazopanib—LYN—nervous system—schizophrenia	0.000817	0.00415	CbGeAlD
Pazopanib—FGFR3—nervous system—schizophrenia	0.000813	0.00413	CbGeAlD
Pazopanib—RIOK2—nervous system—schizophrenia	0.000813	0.00413	CbGeAlD
Pazopanib—MAP3K19—nervous system—schizophrenia	0.000804	0.00409	CbGeAlD
Pazopanib—BMPR1B—nervous system—schizophrenia	0.000804	0.00409	CbGeAlD
Pazopanib—STK16—central nervous system—schizophrenia	0.000795	0.00404	CbGeAlD
Pazopanib—TAOK1—brain—schizophrenia	0.000788	0.00401	CbGeAlD
Pazopanib—TAOK3—telencephalon—schizophrenia	0.000787	0.004	CbGeAlD
Pazopanib—LYN—central nervous system—schizophrenia	0.000786	0.004	CbGeAlD
Pazopanib—PDGFRA—telencephalon—schizophrenia	0.000783	0.00398	CbGeAlD
Pazopanib—RIOK2—central nervous system—schizophrenia	0.000782	0.00398	CbGeAlD
Pazopanib—FGFR3—central nervous system—schizophrenia	0.000782	0.00398	CbGeAlD
Pazopanib—FLT4—blood—schizophrenia	0.000781	0.00397	CbGeAlD
Pazopanib—STK36—endocrine gland—schizophrenia	0.00078	0.00397	CbGeAlD
Pazopanib—PIP4K2C—blood—schizophrenia	0.000777	0.00395	CbGeAlD
Pazopanib—STK16—cerebellum—schizophrenia	0.000777	0.00395	CbGeAlD
Pazopanib—MAP3K19—central nervous system—schizophrenia	0.000774	0.00394	CbGeAlD
Pazopanib—BMPR1B—central nervous system—schizophrenia	0.000774	0.00394	CbGeAlD
Pazopanib—PI4KB—endocrine gland—schizophrenia	0.000768	0.0039	CbGeAlD
Pazopanib—KDR—forebrain—schizophrenia	0.000768	0.0039	CbGeAlD
Pazopanib—PIP4K2C—midbrain—schizophrenia	0.000767	0.0039	CbGeAlD
Pazopanib—RIOK2—cerebellum—schizophrenia	0.000765	0.00389	CbGeAlD
Pazopanib—FGFR3—cerebellum—schizophrenia	0.000765	0.00389	CbGeAlD
Pazopanib—FGFR1—midbrain—schizophrenia	0.000761	0.00387	CbGeAlD
Pazopanib—BMPR1B—cerebellum—schizophrenia	0.000757	0.00385	CbGeAlD
Pazopanib—LIMK2—endocrine gland—schizophrenia	0.000754	0.00383	CbGeAlD
Pazopanib—CSF1R—forebrain—schizophrenia	0.000749	0.00381	CbGeAlD
Pazopanib—SH2B3—brain—schizophrenia	0.000742	0.00377	CbGeAlD
Pazopanib—MAP3K2—blood—schizophrenia	0.000736	0.00374	CbGeAlD
Pazopanib—AURKC—brain—schizophrenia	0.00073	0.00371	CbGeAlD
Pazopanib—STK36—nervous system—schizophrenia	0.00073	0.00371	CbGeAlD
Pazopanib—PI4KB—nervous system—schizophrenia	0.000719	0.00365	CbGeAlD
Pazopanib—MAP2K5—telencephalon—schizophrenia	0.000706	0.00359	CbGeAlD
Pazopanib—LIMK2—nervous system—schizophrenia	0.000706	0.00359	CbGeAlD
Pazopanib—STK36—central nervous system—schizophrenia	0.000703	0.00357	CbGeAlD
Pazopanib—CYP2C8—blood plasma—schizophrenia	0.000701	0.00357	CbGeAlD
Pazopanib—FLT1—gonad—schizophrenia	0.000697	0.00354	CbGeAlD
Pazopanib—FGF1—blood—schizophrenia	0.000694	0.00353	CbGeAlD
Pazopanib—PI4KB—central nervous system—schizophrenia	0.000692	0.00352	CbGeAlD
Pazopanib—LCK—blood—schizophrenia	0.00069	0.00351	CbGeAlD
Pazopanib—CSF1R—telencephalon—schizophrenia	0.000689	0.0035	CbGeAlD
Pazopanib—STK36—cerebellum—schizophrenia	0.000687	0.00349	CbGeAlD
Pazopanib—FGF1—midbrain—schizophrenia	0.000685	0.00348	CbGeAlD
Pazopanib—LIMK2—central nervous system—schizophrenia	0.000679	0.00345	CbGeAlD
Pazopanib—FLT4—endocrine gland—schizophrenia	0.000677	0.00344	CbGeAlD
Pazopanib—PI4KB—cerebellum—schizophrenia	0.000676	0.00344	CbGeAlD
Pazopanib—PIP4K2C—endocrine gland—schizophrenia	0.000674	0.00343	CbGeAlD
Pazopanib—PLK4—brain—schizophrenia	0.000668	0.0034	CbGeAlD
Pazopanib—LIMK2—cerebellum—schizophrenia	0.000664	0.00338	CbGeAlD
Pazopanib—STK10—gonad—schizophrenia	0.00066	0.00335	CbGeAlD
Pazopanib—CYP1A2—blood plasma—schizophrenia	0.000656	0.00334	CbGeAlD
Pazopanib—FGFR2—blood—schizophrenia	0.000655	0.00333	CbGeAlD
Pazopanib—PDGFRA—gonad—schizophrenia	0.000653	0.00332	CbGeAlD
Pazopanib—MAP3K2—endocrine gland—schizophrenia	0.000639	0.00325	CbGeAlD
Pazopanib—STK16—brain—schizophrenia	0.000631	0.00321	CbGeAlD
Pazopanib—PIP4K2C—nervous system—schizophrenia	0.000631	0.00321	CbGeAlD
Pazopanib—KIT—telencephalon—schizophrenia	0.000626	0.00318	CbGeAlD
Pazopanib—LYN—brain—schizophrenia	0.000624	0.00317	CbGeAlD
Pazopanib—RIOK2—brain—schizophrenia	0.000621	0.00316	CbGeAlD
Pazopanib—FGFR3—brain—schizophrenia	0.000621	0.00316	CbGeAlD
Pazopanib—MAP3K19—brain—schizophrenia	0.000615	0.00313	CbGeAlD
Pazopanib—BMPR1B—brain—schizophrenia	0.000615	0.00313	CbGeAlD
Pazopanib—PDGFRB—telencephalon—schizophrenia	0.000611	0.00311	CbGeAlD
Pazopanib—FLT1—blood—schizophrenia	0.000607	0.00309	CbGeAlD
Pazopanib—PIP4K2C—central nervous system—schizophrenia	0.000607	0.00309	CbGeAlD
Pazopanib—FGF1—endocrine gland—schizophrenia	0.000602	0.00306	CbGeAlD
Pazopanib—EPHB6—blood—schizophrenia	0.0006	0.00305	CbGeAlD
Pazopanib—FLT1—midbrain—schizophrenia	0.0006	0.00305	CbGeAlD
Pazopanib—MAP3K2—nervous system—schizophrenia	0.000598	0.00304	CbGeAlD
Pazopanib—PIP4K2C—cerebellum—schizophrenia	0.000593	0.00302	CbGeAlD
Pazopanib—EPHB6—midbrain—schizophrenia	0.000593	0.00301	CbGeAlD
Pazopanib—FGFR1—cerebellum—schizophrenia	0.000589	0.00299	CbGeAlD
Pazopanib—MAP3K2—central nervous system—schizophrenia	0.000576	0.00293	CbGeAlD
Pazopanib—CSF1R—gonad—schizophrenia	0.000575	0.00292	CbGeAlD
Pazopanib—STK10—blood—schizophrenia	0.000575	0.00292	CbGeAlD
Pazopanib—TAOK3—blood—schizophrenia	0.000573	0.00291	CbGeAlD
Pazopanib—PDGFRA—blood—schizophrenia	0.000569	0.00289	CbGeAlD
Pazopanib—FGFR2—endocrine gland—schizophrenia	0.000568	0.00289	CbGeAlD
Pazopanib—TAOK3—midbrain—schizophrenia	0.000566	0.00288	CbGeAlD
Pazopanib—FGF1—nervous system—schizophrenia	0.000563	0.00286	CbGeAlD
Pazopanib—MAP3K2—cerebellum—schizophrenia	0.000563	0.00286	CbGeAlD
Pazopanib—STK36—brain—schizophrenia	0.000558	0.00284	CbGeAlD
Pazopanib—PI4KB—brain—schizophrenia	0.000549	0.00279	CbGeAlD
Pazopanib—UGT1A1—blood—schizophrenia	0.000543	0.00276	CbGeAlD
Pazopanib—FGF1—central nervous system—schizophrenia	0.000542	0.00276	CbGeAlD
Pazopanib—LIMK2—brain—schizophrenia	0.000539	0.00274	CbGeAlD
Pazopanib—FGFR2—nervous system—schizophrenia	0.000532	0.0027	CbGeAlD
Pazopanib—FGF1—cerebellum—schizophrenia	0.00053	0.00269	CbGeAlD
Pazopanib—FLT1—endocrine gland—schizophrenia	0.000527	0.00268	CbGeAlD
Pazopanib—KIT—gonad—schizophrenia	0.000522	0.00265	CbGeAlD
Pazopanib—MAP2K5—blood—schizophrenia	0.000513	0.00261	CbGeAlD
Pazopanib—KDR—blood—schizophrenia	0.000513	0.00261	CbGeAlD
Pazopanib—FGFR2—central nervous system—schizophrenia	0.000512	0.0026	CbGeAlD
Pazopanib—PDGFRB—gonad—schizophrenia	0.00051	0.00259	CbGeAlD
Pazopanib—KDR—midbrain—schizophrenia	0.000507	0.00258	CbGeAlD
Pazopanib—MAP2K5—midbrain—schizophrenia	0.000507	0.00258	CbGeAlD
Pazopanib—CSF1R—blood—schizophrenia	0.000501	0.00255	CbGeAlD
Pazopanib—FGFR2—cerebellum—schizophrenia	0.000501	0.00254	CbGeAlD
Pazopanib—STK10—endocrine gland—schizophrenia	0.000499	0.00254	CbGeAlD
Pazopanib—TAOK3—endocrine gland—schizophrenia	0.000497	0.00253	CbGeAlD
Pazopanib—CSF1R—midbrain—schizophrenia	0.000495	0.00252	CbGeAlD
Pazopanib—PDGFRA—endocrine gland—schizophrenia	0.000494	0.00251	CbGeAlD
Pazopanib—FLT1—nervous system—schizophrenia	0.000493	0.00251	CbGeAlD
Pazopanib—EPHB6—nervous system—schizophrenia	0.000487	0.00248	CbGeAlD
Pazopanib—FLT4—brain—schizophrenia	0.000485	0.00246	CbGeAlD
Pazopanib—PIP4K2C—brain—schizophrenia	0.000482	0.00245	CbGeAlD
Pazopanib—FGFR1—brain—schizophrenia	0.000478	0.00243	CbGeAlD
Pazopanib—CYP3A4—blood plasma—schizophrenia	0.000475	0.00241	CbGeAlD
Pazopanib—FLT1—central nervous system—schizophrenia	0.000475	0.00241	CbGeAlD
Pazopanib—UGT1A1—endocrine gland—schizophrenia	0.000471	0.00239	CbGeAlD
Pazopanib—EPHB6—central nervous system—schizophrenia	0.000469	0.00239	CbGeAlD
Pazopanib—CYP2D6—blood plasma—schizophrenia	0.000467	0.00238	CbGeAlD
Pazopanib—STK10—nervous system—schizophrenia	0.000467	0.00237	CbGeAlD
Pazopanib—TAOK3—nervous system—schizophrenia	0.000465	0.00236	CbGeAlD
Pazopanib—FLT1—cerebellum—schizophrenia	0.000464	0.00236	CbGeAlD
Pazopanib—PDGFRA—nervous system—schizophrenia	0.000462	0.00235	CbGeAlD
Pazopanib—EPHB6—cerebellum—schizophrenia	0.000459	0.00233	CbGeAlD
Pazopanib—MAP3K2—brain—schizophrenia	0.000457	0.00232	CbGeAlD
Pazopanib—KIT—blood—schizophrenia	0.000455	0.00231	CbGeAlD
Pazopanib—SLCO1B1—blood—schizophrenia	0.000452	0.0023	CbGeAlD
Pazopanib—STK10—central nervous system—schizophrenia	0.000449	0.00228	CbGeAlD
Pazopanib—KIT—midbrain—schizophrenia	0.000449	0.00228	CbGeAlD
Pazopanib—TAOK3—central nervous system—schizophrenia	0.000448	0.00228	CbGeAlD
Pazopanib—KDR—endocrine gland—schizophrenia	0.000445	0.00226	CbGeAlD
Pazopanib—MAP2K5—endocrine gland—schizophrenia	0.000445	0.00226	CbGeAlD
Pazopanib—PDGFRA—central nervous system—schizophrenia	0.000445	0.00226	CbGeAlD
Pazopanib—PDGFRB—blood—schizophrenia	0.000444	0.00226	CbGeAlD
Pazopanib—STK10—cerebellum—schizophrenia	0.000439	0.00223	CbGeAlD
Pazopanib—PDGFRB—midbrain—schizophrenia	0.000439	0.00223	CbGeAlD
Pazopanib—TAOK3—cerebellum—schizophrenia	0.000437	0.00222	CbGeAlD
Pazopanib—PDGFRA—cerebellum—schizophrenia	0.000435	0.00221	CbGeAlD
Pazopanib—CSF1R—endocrine gland—schizophrenia	0.000435	0.00221	CbGeAlD
Pazopanib—FGF1—brain—schizophrenia	0.00043	0.00219	CbGeAlD
Pazopanib—KDR—nervous system—schizophrenia	0.000417	0.00212	CbGeAlD
Pazopanib—MAP2K5—nervous system—schizophrenia	0.000417	0.00212	CbGeAlD
Pazopanib—CSF1R—nervous system—schizophrenia	0.000407	0.00207	CbGeAlD
Pazopanib—FGFR2—brain—schizophrenia	0.000407	0.00207	CbGeAlD
Pazopanib—KDR—central nervous system—schizophrenia	0.000401	0.00204	CbGeAlD
Pazopanib—MAP2K5—central nervous system—schizophrenia	0.000401	0.00204	CbGeAlD
Pazopanib—KIT—endocrine gland—schizophrenia	0.000395	0.00201	CbGeAlD
Pazopanib—KDR—cerebellum—schizophrenia	0.000392	0.00199	CbGeAlD
Pazopanib—MAP2K5—cerebellum—schizophrenia	0.000392	0.00199	CbGeAlD
Pazopanib—SLCO1B1—endocrine gland—schizophrenia	0.000392	0.00199	CbGeAlD
Pazopanib—CSF1R—central nervous system—schizophrenia	0.000392	0.00199	CbGeAlD
Pazopanib—PDGFRB—endocrine gland—schizophrenia	0.000385	0.00196	CbGeAlD
Pazopanib—CSF1R—cerebellum—schizophrenia	0.000383	0.00195	CbGeAlD
Pazopanib—FLT1—brain—schizophrenia	0.000377	0.00192	CbGeAlD
Pazopanib—EPHB6—brain—schizophrenia	0.000372	0.00189	CbGeAlD
Pazopanib—KIT—nervous system—schizophrenia	0.000369	0.00188	CbGeAlD
Pazopanib—PDGFRB—nervous system—schizophrenia	0.000361	0.00183	CbGeAlD
Pazopanib—STK10—brain—schizophrenia	0.000357	0.00181	CbGeAlD
Pazopanib—KIT—central nervous system—schizophrenia	0.000356	0.00181	CbGeAlD
Pazopanib—TAOK3—brain—schizophrenia	0.000355	0.00181	CbGeAlD
Pazopanib—PDGFRA—brain—schizophrenia	0.000353	0.0018	CbGeAlD
Pazopanib—KIT—cerebellum—schizophrenia	0.000348	0.00177	CbGeAlD
Pazopanib—PDGFRB—central nervous system—schizophrenia	0.000347	0.00177	CbGeAlD
Pazopanib—ABCG2—telencephalon—schizophrenia	0.000343	0.00175	CbGeAlD
Pazopanib—PDGFRB—cerebellum—schizophrenia	0.000339	0.00173	CbGeAlD
Pazopanib—ABCB1—blood plasma—schizophrenia	0.000336	0.00171	CbGeAlD
Pazopanib—KDR—brain—schizophrenia	0.000319	0.00162	CbGeAlD
Pazopanib—MAP2K5—brain—schizophrenia	0.000319	0.00162	CbGeAlD
Pazopanib—CSF1R—brain—schizophrenia	0.000311	0.00158	CbGeAlD
Pazopanib—KIT—brain—schizophrenia	0.000282	0.00144	CbGeAlD
Pazopanib—PDGFRB—brain—schizophrenia	0.000276	0.0014	CbGeAlD
Pazopanib—CYP2C8—blood—schizophrenia	0.000257	0.00131	CbGeAlD
Pazopanib—CYP2D6—forebrain—schizophrenia	0.000256	0.0013	CbGeAlD
Pazopanib—ABCG2—blood—schizophrenia	0.00025	0.00127	CbGeAlD
Pazopanib—ABCG2—midbrain—schizophrenia	0.000247	0.00125	CbGeAlD
Pazopanib—CYP1A2—blood—schizophrenia	0.00024	0.00122	CbGeAlD
Pazopanib—CYP2D6—telencephalon—schizophrenia	0.000235	0.0012	CbGeAlD
Pazopanib—CYP2C8—endocrine gland—schizophrenia	0.000223	0.00113	CbGeAlD
Pazopanib—CYP1A2—endocrine gland—schizophrenia	0.000208	0.00106	CbGeAlD
Pazopanib—ABCG2—cerebellum—schizophrenia	0.000191	0.00097	CbGeAlD
Pazopanib—ABCB1—forebrain—schizophrenia	0.000184	0.000936	CbGeAlD
Pazopanib—CYP3A4—blood—schizophrenia	0.000174	0.000885	CbGeAlD
Pazopanib—CYP2D6—blood—schizophrenia	0.000171	0.000871	CbGeAlD
Pazopanib—ABCB1—telencephalon—schizophrenia	0.000169	0.000861	CbGeAlD
Pazopanib—CYP2C8—brain—schizophrenia	0.000159	0.00081	CbGeAlD
Pazopanib—ABCG2—brain—schizophrenia	0.000155	0.000788	CbGeAlD
Pazopanib—CYP3A4—endocrine gland—schizophrenia	0.000151	0.000767	CbGeAlD
Pazopanib—CYP2D6—endocrine gland—schizophrenia	0.000148	0.000755	CbGeAlD
Pazopanib—ABCB1—gonad—schizophrenia	0.000141	0.000719	CbGeAlD
Pazopanib—CYP3A4—nervous system—schizophrenia	0.000141	0.000718	CbGeAlD
Pazopanib—CYP2D6—nervous system—schizophrenia	0.000139	0.000707	CbGeAlD
Pazopanib—CYP3A4—central nervous system—schizophrenia	0.000136	0.000691	CbGeAlD
Pazopanib—CYP2D6—central nervous system—schizophrenia	0.000134	0.00068	CbGeAlD
Pazopanib—CYP2D6—cerebellum—schizophrenia	0.000131	0.000665	CbGeAlD
Pazopanib—ABCB1—blood—schizophrenia	0.000123	0.000626	CbGeAlD
Pazopanib—ABCB1—midbrain—schizophrenia	0.000122	0.000618	CbGeAlD
Pazopanib—ABCB1—endocrine gland—schizophrenia	0.000107	0.000543	CbGeAlD
Pazopanib—CYP2D6—brain—schizophrenia	0.000106	0.00054	CbGeAlD
Pazopanib—ABCB1—nervous system—schizophrenia	0.0001	0.000508	CbGeAlD
Pazopanib—ABCB1—central nervous system—schizophrenia	9.63e-05	0.000489	CbGeAlD
Pazopanib—ABCB1—cerebellum—schizophrenia	9.41e-05	0.000478	CbGeAlD
Pazopanib—ABCB1—brain—schizophrenia	7.64e-05	0.000389	CbGeAlD
Pazopanib—CYP3A4—Metabolism—PIP4K2A—schizophrenia	5.58e-06	2.09e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—APOE—schizophrenia	5.57e-06	2.08e-05	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—TPH2—schizophrenia	5.53e-06	2.07e-05	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—CACNB2—schizophrenia	5.53e-06	2.07e-05	CbGpPWpGaD
Pazopanib—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—schizophrenia	5.53e-06	2.07e-05	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—APOA1—schizophrenia	5.52e-06	2.06e-05	CbGpPWpGaD
Pazopanib—FGFR1—Immune System—IL1B—schizophrenia	5.5e-06	2.06e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—APOA1—schizophrenia	5.5e-06	2.06e-05	CbGpPWpGaD
Pazopanib—UGT1A1—Metabolism—APOE—schizophrenia	5.49e-06	2.06e-05	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G4A—schizophrenia	5.49e-06	2.05e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Immune System—IL1B—schizophrenia	5.49e-06	2.05e-05	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—ERBB3—schizophrenia	5.49e-06	2.05e-05	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—PRKD1—schizophrenia	5.48e-06	2.05e-05	CbGpPWpGaD
Pazopanib—FGFR2—Innate Immune System—AKT1—schizophrenia	5.48e-06	2.05e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—S100B—schizophrenia	5.44e-06	2.03e-05	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—DPYD—schizophrenia	5.44e-06	2.03e-05	CbGpPWpGaD
Pazopanib—UGT1A1—Metabolism—APOA1—schizophrenia	5.43e-06	2.03e-05	CbGpPWpGaD
Pazopanib—SLCO1B1—Metabolism—MTHFR—schizophrenia	5.41e-06	2.02e-05	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—GAPDH—schizophrenia	5.39e-06	2.02e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—HTR2A—schizophrenia	5.39e-06	2.02e-05	CbGpPWpGaD
Pazopanib—LCK—Immune System—GSK3B—schizophrenia	5.39e-06	2.02e-05	CbGpPWpGaD
Pazopanib—KIT—Innate Immune System—AKT1—schizophrenia	5.38e-06	2.01e-05	CbGpPWpGaD
Pazopanib—LCK—Immune System—FOS—schizophrenia	5.36e-06	2e-05	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—CLOCK—schizophrenia	5.35e-06	2e-05	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—ESR1—schizophrenia	5.33e-06	1.99e-05	CbGpPWpGaD
Pazopanib—ABCB1—Transmembrane transport of small molecules—APOA1—schizophrenia	5.32e-06	1.99e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—ESR1—schizophrenia	5.31e-06	1.99e-05	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—HTR2A—schizophrenia	5.28e-06	1.98e-05	CbGpPWpGaD
Pazopanib—FGFR2—Immune System—EP300—schizophrenia	5.28e-06	1.97e-05	CbGpPWpGaD
Pazopanib—FLT4—Signaling Pathways—AKT1—schizophrenia	5.26e-06	1.97e-05	CbGpPWpGaD
Pazopanib—FGFR2—Adaptive Immune System—AKT1—schizophrenia	5.26e-06	1.97e-05	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—TPH2—schizophrenia	5.21e-06	1.95e-05	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—CACNB2—schizophrenia	5.21e-06	1.95e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—ERBB4—schizophrenia	5.2e-06	1.95e-05	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—GSK3B—schizophrenia	5.19e-06	1.94e-05	CbGpPWpGaD
Pazopanib—KIT—Immune System—EP300—schizophrenia	5.18e-06	1.94e-05	CbGpPWpGaD
Pazopanib—KIT—Adaptive Immune System—AKT1—schizophrenia	5.16e-06	1.93e-05	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—DPYD—schizophrenia	5.13e-06	1.92e-05	CbGpPWpGaD
Pazopanib—FGFR1—Innate Immune System—AKT1—schizophrenia	5.1e-06	1.91e-05	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—GSK3B—schizophrenia	5.09e-06	1.9e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Innate Immune System—AKT1—schizophrenia	5.09e-06	1.9e-05	CbGpPWpGaD
Pazopanib—LYN—Developmental Biology—AKT1—schizophrenia	5.08e-06	1.9e-05	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—CYP2D6—schizophrenia	5.07e-06	1.9e-05	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—SNAP25—schizophrenia	5.07e-06	1.9e-05	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—CACNA1C—schizophrenia	5.06e-06	1.89e-05	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—CYP26B1—schizophrenia	5.04e-06	1.89e-05	CbGpPWpGaD
Pazopanib—SLCO1B1—Metabolism—APOE—schizophrenia	5.04e-06	1.88e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—APOE—schizophrenia	5.01e-06	1.88e-05	CbGpPWpGaD
Pazopanib—ABCG2—Metabolism—MTHFR—schizophrenia	5.01e-06	1.87e-05	CbGpPWpGaD
Pazopanib—LYN—Hemostasis—AKT1—schizophrenia	4.99e-06	1.87e-05	CbGpPWpGaD
Pazopanib—SLCO1B1—Metabolism—APOA1—schizophrenia	4.98e-06	1.86e-05	CbGpPWpGaD
Pazopanib—LCK—Disease—GSK3B—schizophrenia	4.98e-06	1.86e-05	CbGpPWpGaD
Pazopanib—FGFR3—Signaling Pathways—EP300—schizophrenia	4.96e-06	1.86e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—APOA1—schizophrenia	4.96e-06	1.85e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Immune System—IL1B—schizophrenia	4.94e-06	1.85e-05	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—PIK3C2A—schizophrenia	4.93e-06	1.84e-05	CbGpPWpGaD
Pazopanib—FGFR1—Immune System—EP300—schizophrenia	4.92e-06	1.84e-05	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—APOE—schizophrenia	4.91e-06	1.84e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Immune System—EP300—schizophrenia	4.91e-06	1.83e-05	CbGpPWpGaD
Pazopanib—FGFR1—Adaptive Immune System—AKT1—schizophrenia	4.9e-06	1.83e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—PLA2G4A—schizophrenia	4.89e-06	1.83e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Adaptive Immune System—AKT1—schizophrenia	4.89e-06	1.83e-05	CbGpPWpGaD
Pazopanib—FGFR2—Disease—EP300—schizophrenia	4.87e-06	1.82e-05	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—APOA1—schizophrenia	4.85e-06	1.82e-05	CbGpPWpGaD
Pazopanib—LCK—Hemostasis—TP53—schizophrenia	4.84e-06	1.81e-05	CbGpPWpGaD
Pazopanib—LYN—Immune System—IL1B—schizophrenia	4.84e-06	1.81e-05	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—GSK3B—schizophrenia	4.83e-06	1.81e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—GSK3B—schizophrenia	4.82e-06	1.8e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—NRG1—schizophrenia	4.8e-06	1.8e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—ESR1—schizophrenia	4.79e-06	1.79e-05	CbGpPWpGaD
Pazopanib—KIT—Disease—EP300—schizophrenia	4.79e-06	1.79e-05	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—CACNA1C—schizophrenia	4.77e-06	1.78e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—MEF2C—schizophrenia	4.76e-06	1.78e-05	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—ESR1—schizophrenia	4.69e-06	1.75e-05	CbGpPWpGaD
Pazopanib—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—schizophrenia	4.67e-06	1.75e-05	CbGpPWpGaD
Pazopanib—ABCG2—Metabolism—APOE—schizophrenia	4.66e-06	1.74e-05	CbGpPWpGaD
Pazopanib—FLT1—Signaling Pathways—TP53—schizophrenia	4.65e-06	1.74e-05	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—PIK3C2A—schizophrenia	4.64e-06	1.74e-05	CbGpPWpGaD
Pazopanib—FGFR3—Immune System—AKT1—schizophrenia	4.64e-06	1.73e-05	CbGpPWpGaD
Pazopanib—ABCG2—Metabolism—APOA1—schizophrenia	4.61e-06	1.72e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—YWHAZ—schizophrenia	4.6e-06	1.72e-05	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—CYP1A2—schizophrenia	4.59e-06	1.72e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Innate Immune System—AKT1—schizophrenia	4.59e-06	1.72e-05	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—GAPDH—schizophrenia	4.57e-06	1.71e-05	CbGpPWpGaD
Pazopanib—FGFR1—Disease—EP300—schizophrenia	4.54e-06	1.7e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Disease—EP300—schizophrenia	4.53e-06	1.69e-05	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—CLOCK—schizophrenia	4.53e-06	1.69e-05	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—TH—schizophrenia	4.52e-06	1.69e-05	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism of lipids and lipoproteins—APOE—schizophrenia	4.52e-06	1.69e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—ERBB3—schizophrenia	4.5e-06	1.68e-05	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—GCLM—schizophrenia	4.49e-06	1.68e-05	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—TPH1—schizophrenia	4.49e-06	1.68e-05	CbGpPWpGaD
Pazopanib—LYN—Innate Immune System—AKT1—schizophrenia	4.49e-06	1.68e-05	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—schizophrenia	4.47e-06	1.67e-05	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—EP300—schizophrenia	4.43e-06	1.66e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Immune System—EP300—schizophrenia	4.42e-06	1.65e-05	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—SNAP25—schizophrenia	4.42e-06	1.65e-05	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—CYP2D6—schizophrenia	4.42e-06	1.65e-05	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—TPH2—schizophrenia	4.41e-06	1.65e-05	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—CACNB2—schizophrenia	4.41e-06	1.65e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Adaptive Immune System—AKT1—schizophrenia	4.4e-06	1.65e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—GSK3B—schizophrenia	4.34e-06	1.62e-05	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—DPYD—schizophrenia	4.34e-06	1.62e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—HTR2A—schizophrenia	4.33e-06	1.62e-05	CbGpPWpGaD
Pazopanib—LYN—Immune System—EP300—schizophrenia	4.33e-06	1.62e-05	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—EP300—schizophrenia	4.32e-06	1.62e-05	CbGpPWpGaD
Pazopanib—LYN—Adaptive Immune System—AKT1—schizophrenia	4.31e-06	1.61e-05	CbGpPWpGaD
Pazopanib—FGFR3—Disease—AKT1—schizophrenia	4.28e-06	1.6e-05	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—GSK3B—schizophrenia	4.25e-06	1.59e-05	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—PRKD1—schizophrenia	4.23e-06	1.58e-05	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—SNAP25—schizophrenia	4.17e-06	1.56e-05	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—EP300—schizophrenia	4.12e-06	1.54e-05	CbGpPWpGaD
Pazopanib—LCK—Hemostasis—AKT1—schizophrenia	4.09e-06	1.53e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Disease—EP300—schizophrenia	4.08e-06	1.53e-05	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—CACNA1C—schizophrenia	4.04e-06	1.51e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—APOE—schizophrenia	4.02e-06	1.51e-05	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—CYP1A2—schizophrenia	4e-06	1.5e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—APOA1—schizophrenia	3.98e-06	1.49e-05	CbGpPWpGaD
Pazopanib—LCK—Immune System—IL1B—schizophrenia	3.97e-06	1.48e-05	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—TH—schizophrenia	3.94e-06	1.47e-05	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—PIK3C2A—schizophrenia	3.93e-06	1.47e-05	CbGpPWpGaD
Pazopanib—FLT1—Signaling Pathways—AKT1—schizophrenia	3.93e-06	1.47e-05	CbGpPWpGaD
Pazopanib—FGF1—Immune System—AKT1—schizophrenia	3.85e-06	1.44e-05	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—COMT—schizophrenia	3.84e-06	1.44e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—ESR1—schizophrenia	3.84e-06	1.44e-05	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—GSTP1—schizophrenia	3.83e-06	1.43e-05	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—MAOA—schizophrenia	3.82e-06	1.43e-05	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—CYP1A2—schizophrenia	3.77e-06	1.41e-05	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—TH—schizophrenia	3.71e-06	1.39e-05	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism of lipids and lipoproteins—EP300—schizophrenia	3.7e-06	1.38e-05	CbGpPWpGaD
Pazopanib—LCK—Innate Immune System—AKT1—schizophrenia	3.68e-06	1.38e-05	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—ABCB1—schizophrenia	3.62e-06	1.35e-05	CbGpPWpGaD
Pazopanib—FGF1—Disease—AKT1—schizophrenia	3.56e-06	1.33e-05	CbGpPWpGaD
Pazopanib—FGFR3—Signaling Pathways—TP53—schizophrenia	3.55e-06	1.33e-05	CbGpPWpGaD
Pazopanib—LCK—Immune System—EP300—schizophrenia	3.55e-06	1.33e-05	CbGpPWpGaD
Pazopanib—LCK—Adaptive Immune System—AKT1—schizophrenia	3.53e-06	1.32e-05	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—CYP2D6—schizophrenia	3.53e-06	1.32e-05	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—SNAP25—schizophrenia	3.53e-06	1.32e-05	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—GAPDH—schizophrenia	3.53e-06	1.32e-05	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—PLA2G4A—schizophrenia	3.52e-06	1.32e-05	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—GSTM1—schizophrenia	3.52e-06	1.32e-05	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—CLOCK—schizophrenia	3.5e-06	1.31e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—GSK3B—schizophrenia	3.49e-06	1.3e-05	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—EP300—schizophrenia	3.41e-06	1.28e-05	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—TPH2—schizophrenia	3.41e-06	1.27e-05	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—CACNB2—schizophrenia	3.41e-06	1.27e-05	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—DPYD—schizophrenia	3.35e-06	1.25e-05	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—EP300—schizophrenia	3.35e-06	1.25e-05	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—COMT—schizophrenia	3.35e-06	1.25e-05	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—GSTP1—schizophrenia	3.33e-06	1.25e-05	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—MAOA—schizophrenia	3.33e-06	1.24e-05	CbGpPWpGaD
Pazopanib—LCK—Disease—EP300—schizophrenia	3.27e-06	1.22e-05	CbGpPWpGaD
Pazopanib—FGFR2—Immune System—AKT1—schizophrenia	3.19e-06	1.19e-05	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—EP300—schizophrenia	3.18e-06	1.19e-05	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—TP53—schizophrenia	3.17e-06	1.19e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—EP300—schizophrenia	3.17e-06	1.19e-05	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—COMT—schizophrenia	3.16e-06	1.18e-05	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—TH—schizophrenia	3.14e-06	1.18e-05	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—GSTP1—schizophrenia	3.14e-06	1.18e-05	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—MAOA—schizophrenia	3.13e-06	1.17e-05	CbGpPWpGaD
Pazopanib—KIT—Immune System—AKT1—schizophrenia	3.13e-06	1.17e-05	CbGpPWpGaD
Pazopanib—UGT1A1—Metabolism—EP300—schizophrenia	3.13e-06	1.17e-05	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—CACNA1C—schizophrenia	3.12e-06	1.17e-05	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—MTHFR—schizophrenia	3.11e-06	1.16e-05	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—TP53—schizophrenia	3.09e-06	1.16e-05	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—GSTM1—schizophrenia	3.06e-06	1.15e-05	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—PLA2G4A—schizophrenia	3.06e-06	1.15e-05	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—PIK3C2A—schizophrenia	3.04e-06	1.14e-05	CbGpPWpGaD
Pazopanib—FGFR3—Signaling Pathways—AKT1—schizophrenia	3e-06	1.12e-05	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—ABCB1—schizophrenia	2.97e-06	1.11e-05	CbGpPWpGaD
Pazopanib—FGFR1—Immune System—AKT1—schizophrenia	2.97e-06	1.11e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Immune System—AKT1—schizophrenia	2.96e-06	1.11e-05	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—TP53—schizophrenia	2.95e-06	1.1e-05	CbGpPWpGaD
Pazopanib—FGFR2—Disease—AKT1—schizophrenia	2.94e-06	1.1e-05	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—APOE—schizophrenia	2.89e-06	1.08e-05	CbGpPWpGaD
Pazopanib—KIT—Disease—AKT1—schizophrenia	2.89e-06	1.08e-05	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—PLA2G4A—schizophrenia	2.89e-06	1.08e-05	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—GSTM1—schizophrenia	2.89e-06	1.08e-05	CbGpPWpGaD
Pazopanib—SLCO1B1—Metabolism—EP300—schizophrenia	2.87e-06	1.07e-05	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—APOA1—schizophrenia	2.86e-06	1.07e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—EP300—schizophrenia	2.86e-06	1.07e-05	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—EP300—schizophrenia	2.8e-06	1.05e-05	CbGpPWpGaD
Pazopanib—FGFR1—Disease—AKT1—schizophrenia	2.74e-06	1.03e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Disease—AKT1—schizophrenia	2.74e-06	1.02e-05	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—SNAP25—schizophrenia	2.72e-06	1.02e-05	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—CYP2D6—schizophrenia	2.72e-06	1.02e-05	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—MTHFR—schizophrenia	2.71e-06	1.01e-05	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—AKT1—schizophrenia	2.68e-06	1e-05	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—COMT—schizophrenia	2.67e-06	1e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Immune System—AKT1—schizophrenia	2.67e-06	9.99e-06	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—GSTP1—schizophrenia	2.66e-06	9.95e-06	CbGpPWpGaD
Pazopanib—ABCG2—Metabolism—EP300—schizophrenia	2.66e-06	9.94e-06	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—MAOA—schizophrenia	2.66e-06	9.93e-06	CbGpPWpGaD
Pazopanib—LYN—Immune System—AKT1—schizophrenia	2.62e-06	9.78e-06	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—AKT1—schizophrenia	2.61e-06	9.77e-06	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism of lipids and lipoproteins—EP300—schizophrenia	2.57e-06	9.63e-06	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—MTHFR—schizophrenia	2.55e-06	9.54e-06	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—APOE—schizophrenia	2.52e-06	9.43e-06	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—ABCB1—schizophrenia	2.52e-06	9.42e-06	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—APOA1—schizophrenia	2.49e-06	9.32e-06	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—AKT1—schizophrenia	2.49e-06	9.32e-06	CbGpPWpGaD
Pazopanib—PDGFRB—Disease—AKT1—schizophrenia	2.47e-06	9.22e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—CYP1A2—schizophrenia	2.46e-06	9.21e-06	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—PLA2G4A—schizophrenia	2.45e-06	9.15e-06	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—GSTM1—schizophrenia	2.45e-06	9.15e-06	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—TP53—schizophrenia	2.44e-06	9.13e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—TH—schizophrenia	2.43e-06	9.08e-06	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—TP53—schizophrenia	2.4e-06	8.97e-06	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—APOE—schizophrenia	2.38e-06	8.88e-06	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—APOA1—schizophrenia	2.35e-06	8.78e-06	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—EP300—schizophrenia	2.29e-06	8.58e-06	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—TP53—schizophrenia	2.28e-06	8.51e-06	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—TP53—schizophrenia	2.27e-06	8.49e-06	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—MTHFR—schizophrenia	2.16e-06	8.08e-06	CbGpPWpGaD
Pazopanib—LCK—Immune System—AKT1—schizophrenia	2.14e-06	8.02e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—COMT—schizophrenia	2.06e-06	7.72e-06	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—AKT1—schizophrenia	2.06e-06	7.71e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—GSTP1—schizophrenia	2.05e-06	7.68e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—MAOA—schizophrenia	2.05e-06	7.66e-06	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—TP53—schizophrenia	2.05e-06	7.65e-06	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—AKT1—schizophrenia	2.02e-06	7.57e-06	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—APOE—schizophrenia	2.01e-06	7.53e-06	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—TP53—schizophrenia	2e-06	7.49e-06	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—APOA1—schizophrenia	1.99e-06	7.44e-06	CbGpPWpGaD
Pazopanib—LCK—Disease—AKT1—schizophrenia	1.98e-06	7.4e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—ABCB1—schizophrenia	1.94e-06	7.27e-06	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—AKT1—schizophrenia	1.92e-06	7.19e-06	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—AKT1—schizophrenia	1.92e-06	7.17e-06	CbGpPWpGaD
Pazopanib—UGT1A1—Metabolism—AKT1—schizophrenia	1.89e-06	7.08e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—PLA2G4A—schizophrenia	1.89e-06	7.06e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—GSTM1—schizophrenia	1.89e-06	7.06e-06	CbGpPWpGaD
Pazopanib—SLCO1B1—Metabolism—AKT1—schizophrenia	1.73e-06	6.49e-06	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—AKT1—schizophrenia	1.73e-06	6.46e-06	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—AKT1—schizophrenia	1.69e-06	6.32e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—MTHFR—schizophrenia	1.67e-06	6.24e-06	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—EP300—schizophrenia	1.65e-06	6.17e-06	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—TP53—schizophrenia	1.64e-06	6.14e-06	CbGpPWpGaD
Pazopanib—ABCG2—Metabolism—AKT1—schizophrenia	1.61e-06	6.01e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—APOE—schizophrenia	1.55e-06	5.81e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—APOA1—schizophrenia	1.54e-06	5.74e-06	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—EP300—schizophrenia	1.44e-06	5.37e-06	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—AKT1—schizophrenia	1.39e-06	5.18e-06	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—EP300—schizophrenia	1.35e-06	5.06e-06	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—EP300—schizophrenia	1.15e-06	4.29e-06	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—AKT1—schizophrenia	9.96e-07	3.73e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—EP300—schizophrenia	8.85e-07	3.31e-06	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—AKT1—schizophrenia	8.68e-07	3.25e-06	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—AKT1—schizophrenia	8.18e-07	3.06e-06	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—AKT1—schizophrenia	6.93e-07	2.59e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—AKT1—schizophrenia	5.35e-07	2e-06	CbGpPWpGaD
